By Michael Erman Oct 7 (Reuters) – The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark US drug prices to lower costs overseas
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By David Shepardson WASHINGTON, Oct 7 (Reuters) - The Federal Communications Commission said on Wednesday…
Oct 7 (Reuters) - Glaukos said on Wednesday patients treated with its late-stage eye disease…
Oct 7 (Reuters) - Levi Strauss raised its annual profit forecast on Wednesday, after benefiting…
(Adds Trump speech, event details in paragraphs 1-2, Musk background in paragraphs 3-4) By Courtney…
By Deena Beasley Oct 7 (Reuters) - Novartis’ experimental del-desiran for a rare type of…
CHICAGO, Oct 7 (Reuters) - Chicago Board of Trade wheat futures fell more than 2%…